📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target. (2021)

First Author: Kennedy E

Attributed to: Therapeutic targeting of refractory/relapsed diffuse large B-cell lymphoma through systems biology funded by UKRI FLF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2020005964

PubMed Identifier: 33512408

Publication URI: http://europepmc.org/abstract/MED/33512408

Type: Journal Article/Review

Volume: 137

Parent Publication: Blood

Issue: 22

ISSN: 0006-4971